HENGYU BIOPH

HENGYU BIOPH is one of the first comprehensive national high-tech enterprises in China that integrates the research, production, registration, application, and sales of marine bio-nucleic acid pharmaceutical raw materials and products, high-end medical devices, and medical beauty products. HENGYU BIOPH is an internationally leading biotechnology company specializing in the research and development of new regenerative materials derived from salmon PDRN in marine biology. It was the first in China to initiate studies on salmon PDRN, PN regenerative medicine, and a series of medical applications. In collaboration with Ocean University of China, the National Laboratory for Marine Science and Technology's Innovative Marine Drug Screening and Evaluation Platform, and Qingdao Institute of Marine Biomedicine, HENGYU BIOPH has established China’s first "national team" for PDRN and PN, completing the vertical industrial chain layout for the R&D, production, sales, and application of salmon PDRN medical regeneration materials and related products, thus advancing the localization of salmon PDRN and PN regenerative medicine in China. HENGYU BIOPH has operated the Meigao Medical Aesthetics Institution for nearly a decade, focusing on the promotion and nationwide distribution of PDRN/PN light medical aesthetics, while also developing its own brand of medical, aesthetic, cosmetic, and functional food products. The vision of HENGYU BIOPH is to become a trustworthy company that delivers health and creates beauty, striving to achieve the enduring dream of health and beauty for all of society.